{
    "clinical_study": {
        "@rank": "79007", 
        "arm_group": [
            {
                "arm_group_label": "dobutamine", 
                "arm_group_type": "Active Comparator", 
                "description": "patient receiving dobutamine"
            }, 
            {
                "arm_group_label": "Levosimendan", 
                "arm_group_type": "Active Comparator", 
                "description": "patient receiving levosimendan"
            }
        ], 
        "brief_summary": {
            "textblock": "This study wants to investigate the hemodynamic changes in cardiopatic patients undergoing\n      major non cardiac surgery, during and after the continuous infusion of levosimendan or\n      dobutamine."
        }, 
        "brief_title": "Levosimendan Versus Dobutamine in Cardiopatic Patients Undergoing Major Non Cardiac Surgery", 
        "condition": "Cardiovascular Diseases", 
        "condition_browse": {
            "mesh_term": "Cardiovascular Diseases"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  EF < 40%, no liver and renal disfynction, chronic cardiopathy\n\n        Exclusion Criteria:\n\n          -  acute coronary syndrome, life expectation <30 days, hemodialysis, ventricular\n             tachycardia/ventricular fibrillation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02012946", 
            "org_study_id": "levodobu"
        }, 
        "intervention": [
            {
                "arm_group_label": "Levosimendan", 
                "description": "patient receiving levosimendan", 
                "intervention_name": "Levosimendan", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "dobutamine", 
                "description": "patient receiving dobutamine", 
                "intervention_name": "Dobutamine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Simendan", 
                "Dobutamine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 11, 2013", 
        "location": {
            "contact": {
                "email": "mavif@tiscali.it", 
                "phone": "00390649970468"
            }, 
            "facility": {
                "address": {
                    "city": "Rome", 
                    "country": "Italy", 
                    "zip": "00100"
                }, 
                "name": "Francesco Pugliese"
            }, 
            "investigator": {
                "last_name": "francesco pugliese", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Italy: Agenzia Italiana del Farmaco AIFA"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "cardiac index", 
            "safety_issue": "No", 
            "time_frame": "1-3 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02012946"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Azienda Policlinico Umberto I", 
            "investigator_full_name": "francesco pugliese", 
            "investigator_title": "professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Azienda Policlinico Umberto I", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Azienda Policlinico Umberto I", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}